Building a Better Health Care System: PhRMA's Patient-Centered Agenda
Industry Effort to Combat COVID-19
The Biopharmaceutical Industry is Leading the Way in Developing New Vaccines and Treatments for COVID-19
PhRMA's Equity Initiative
Working Together to Fight COVID-19
The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.
latest from the
Blog
88%
decline in hiv/aids death rates
Since the 1990s
80%
of 340B volume goes through DSH hospitals even though they make up just 9% of 340B entities.
$2.6
billion
The average cost to develop one new medicine.
8
months
Priority FDA review time thanks to PDUFA
80+
autoimmune diseases
have been identified to-date
7,000
new medicines
Currently in development around the world.
